Innovative peptide-loaded hybrid membrane nanovaccine enables precise personalized immunotherapy for HPV-related cervical diseases.
Saved in:
| Title: | Innovative peptide-loaded hybrid membrane nanovaccine enables precise personalized immunotherapy for HPV-related cervical diseases. |
|---|---|
| Authors: | Wang R; Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan, China., Wang J; Innovative Vaccine and Immunotherapy Research Center, The Second Affiliated Hospital , Zhejiang University School of Medicine, Hangzhou, China., Ruan J; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Gao C; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Hu B; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Chen L; Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan, China., Liao B; Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan, China., Ma D; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Tan S; Innovative Vaccine and Immunotherapy Research Center, The Second Affiliated Hospital , Zhejiang University School of Medicine, Hangzhou, China. tansg@zju.edu.cn., Zhang Y; Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan, China. zhangyuanzhen@whu.edu.cn., Liao S; Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan, China. liaosjmailbox@126.com.; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. liaosjmailbox@126.com.; Senior Department of Obstetrics and Gynecology, Chinese PLA General Hospital, Beijing, China. liaosjmailbox@126.com. |
| Source: | Signal transduction and targeted therapy [Signal Transduct Target Ther] 2026 Jun 03; Vol. 11 (1). Date of Electronic Publication: 2026 Jun 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42236671 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Innovative peptide-loaded hybrid membrane nanovaccine enables precise personalized immunotherapy for HPV-related cervical diseases. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wang+R%22">Wang R</searchLink>; Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; Innovative Vaccine and Immunotherapy Research Center, The Second Affiliated Hospital , Zhejiang University School of Medicine, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22Ruan+J%22">Ruan J</searchLink>; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Gao+C%22">Gao C</searchLink>; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Hu+B%22">Hu B</searchLink>; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Chen+L%22">Chen L</searchLink>; Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Liao+B%22">Liao B</searchLink>; Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Ma+D%22">Ma D</searchLink>; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.<br /><searchLink fieldCode="AU" term="%22Tan+S%22">Tan S</searchLink>; Innovative Vaccine and Immunotherapy Research Center, The Second Affiliated Hospital , Zhejiang University School of Medicine, Hangzhou, China. tansg@zju.edu.cn.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan, China. zhangyuanzhen@whu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Liao+S%22">Liao S</searchLink>; Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan, China. liaosjmailbox@126.com.; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. liaosjmailbox@126.com.; Senior Department of Obstetrics and Gynecology, Chinese PLA General Hospital, Beijing, China. liaosjmailbox@126.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101676423%22">Signal transduction and targeted therapy</searchLink> [Signal Transduct Target Ther] 2026 Jun 03; Vol. 11 (1). <i>Date of Electronic Publication: </i>2026 Jun 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101676423 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-3635 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220593635%22">20593635 </searchLink><i>NLM ISO Abbreviation: </i>Signal Transduct Target Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42236671 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41392-026-02680-x Languages: – Code: eng Text: English Titles: – TitleFull: Innovative peptide-loaded hybrid membrane nanovaccine enables precise personalized immunotherapy for HPV-related cervical diseases. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wang R – PersonEntity: Name: NameFull: Wang J – PersonEntity: Name: NameFull: Ruan J – PersonEntity: Name: NameFull: Gao C – PersonEntity: Name: NameFull: Hu B – PersonEntity: Name: NameFull: Chen L – PersonEntity: Name: NameFull: Liao B – PersonEntity: Name: NameFull: Ma D – PersonEntity: Name: NameFull: Tan S – PersonEntity: Name: NameFull: Zhang Y – PersonEntity: Name: NameFull: Liao S IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 06 Text: 2026 Jun 03 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2059-3635 Numbering: – Type: volume Value: 11 – Type: issue Value: 1 Titles: – TitleFull: Signal transduction and targeted therapy Type: main |
| ResultId | 1 |